Bulk Metallic Glass Biomedical Implant Material: Advanced Compositions, Processing Routes, And Clinical Applications

Fundamental Composition And Structural Characteristics Of Bulk Metallic Glass Biomedical Implant Material

Bulk metallic glass biomedical implant material is defined by its disordered atomic-scale structure, which eliminates grain boundaries and crystallographic defects inherent to conventional metallic implants 11. This amorphous architecture arises from rapid cooling rates (typically 10²–10⁶ K/s) that suppress nucleation and growth of crystalline phases, yielding a metastable glassy state with unique mechanical and chemical properties 7. The absence of dislocation-mediated plasticity results in deformation concentrated in highly localized shear bands 8, a characteristic that governs both the alloy's high strength and its susceptibility to catastrophic failure under certain loading conditions.

Zirconium-Based Bulk Metallic Glass Alloys For Implant Applications

Zirconium-rich compositions dominate the landscape of biomedical bulk metallic glasses due to their intrinsic biocompatibility, high glass-forming ability (GFA), and tunable mechanical properties 6 7 19. A representative Zr-Ti-based alloy system contains at least 25 at.% beryllium and exhibits an amorphous phase volume fraction exceeding 25% by volume, with biological compatibility confirmed through in vitro and in vivo assays 6. More recent formulations eliminate beryllium—a known toxicological concern—by substituting with hafnium, cobalt, or niobium. For example, the alloy Zr₅₉.₂Cu₁₆.₂Ni₁₂.₆Al₉.₆Hf₂.₂Ti₀.₂ achieves a hardness range of 4–9 GPa and is explicitly non-toxic 7, making it suitable for long-term implantation in load-bearing sites such as hip and knee prostheses.

The quinary system Zr₅₅Cu₂₀Al₁₅Co₁₀ and related compositions (e.g., Zr₅₄Ni₁₆Cu₁₄Ti₁₀Al₆, Zr₅₅Cu₂₀Co₁₀Ti₈Al₇) demonstrate critical casting thicknesses ≥5 mm 19 and elastic limits >1500 MPa 13, enabling fabrication of bulk components via conventional casting or additive manufacturing. The addition of 0.5–10 at.% titanium and 0.1–6 at.% niobium further enhances corrosion resistance in simulated body fluid (SBF, pH 7.4 at 37°C), with protection effectiveness against corrosive attack exceeding 58% 14. These alloys exhibit contact angles in the range of 115–134°, indicating hydrophobic surfaces that can be functionalized with bioactive coatings to promote osseointegration 14.

Magnesium-Based Bulk Metallic Glass Composites For Biodegradable Implants

Magnesium-based bulk metallic glass composites address the clinical demand for biodegradable fixation devices that eliminate the need for secondary removal surgeries 1 3. A representative composition comprises a magnesium-based matrix reinforced with TiZr alloy particles, yielding a composite with controlled degradation kinetics and mechanical properties tailored to match cortical bone (elastic modulus ~10–30 GPa). The Mg-based bulk metallic glass exhibits a biodegradation rate of approximately 0.01 mg per unit surface area after 14 days of immersion in SBF or Dulbecco's Modified Eagle Medium (DMEM), with a weight gain of up to 3.1 mg attributed to biomineralization of calcium phosphate phases 14.

The composite's suture anchor application 1 3 leverages the high tensile strength of the TiZr reinforcement (typically >800 MPa) and the bioresorbable nature of the Mg matrix, which degrades via hydrolysis and galvanic corrosion to release Mg²⁺ ions that stimulate osteoblast activity. However, hydrogen gas evolution during degradation remains a challenge, necessitating precise control of alloy composition (e.g., addition of 1–3 at.% rare earth elements such as Y or Gd) and surface passivation treatments (e.g., micro-arc oxidation, fluoride conversion coatings) to modulate corrosion rates to physiologically acceptable levels (<0.5 mm/year) 1.

Titanium-Copper Antimicrobial Bulk Metallic Glass Alloys

Ti-Cu-based bulk metallic glass formulations combine biocompatibility with intrinsic antimicrobial activity, addressing the critical issue of implant-associated infections 4 5. The alloy system Ti₁₀₀₋ₓ₋yCuₓMy (where M = Zr, Nb, Ta, Pd, or Co; x = 5–30 at.%; y = 0–50 at.%) can be processed via additive manufacturing (e.g., selective laser melting, electron beam melting) to produce fully amorphous, amorphous-β-titanium, amorphous-copper, or amorphous-(Ti,M)₂Cu phasic structures 4. Copper content in the range of 10–20 at.% provides sustained Cu²⁺ ion release (typically 0.1–1 ppm over 7 days in phosphate-buffered saline), which disrupts bacterial cell membranes and inhibits biofilm formation by Staphylococcus aureus and Escherichia coli with >99.9% efficacy 4.

The Ti₄₇Cu₃₈Zr₇.₅Fe₂.₅Sn₂Si₁Ag₂ alloy, optimized for additive manufacturing, exhibits a glass transition temperature (Tg) of ~420°C, a supercooled liquid region (ΔTx = Tx − Tg) of ~50°C, and a critical cooling rate of ~10³ K/s, enabling layer-by-layer fabrication of complex geometries (e.g., porous scaffolds with 40–70% porosity and pore sizes of 200–500 μm) 5. Powder particles for additive manufacturing possess low surface roughness (Ra < 2 μm) and high circularity (>0.95), ensuring consistent flowability and layer density 5. The resulting implants demonstrate compressive yield strengths of 1800–2200 MPa, elastic moduli of 90–110 GPa, and plastic strain to failure of 1–3%, positioning them as candidates for dental implants, spinal fusion cages, and fracture fixation plates 5.

Processing Routes And Manufacturing Techniques For Bulk Metallic Glass Biomedical Implant Material

Rapid Solidification And Casting Methods

The fabrication of bulk metallic glass biomedical implant material relies on achieving cooling rates sufficient to bypass crystallization during solidification. Conventional methods include copper mold casting, where molten alloy is injected into water-cooled copper molds with cavity dimensions of 2–10 mm, yielding rods or plates with fully amorphous microstructures 19. For Zr-rich alloys, critical casting thicknesses of 5–15 mm are routinely achieved, with larger sections (up to 50 mm diameter) possible in compositions with exceptionally high GFA, such as Zr₄₁.₂Ti₁₃.₈Cu₁₂.₅Ni₁₀Be₂₂.₅ 6.

Suction casting and tilt-casting variants enable production of near-net-shape components (e.g., femoral stems, acetabular cups) with dimensional tolerances of ±0.1 mm, reducing the need for extensive post-processing machining 13. The supercooled liquid region (ΔTx = 40–80°C for most biomedical BMGs) permits thermoplastic forming at temperatures between Tg and the onset of crystallization (Tx), where viscosity drops to 10⁶–10⁹ Pa·s, allowing blow molding, embossing, or hot pressing of complex geometries 17. For example, BMG sheets with thicknesses of 0.5–2 mm can be thermoformed at 420–460°C under pressures of 1–5 MPa to produce cranial plates or maxillofacial reconstruction implants 17.

Additive Manufacturing Of Bulk Metallic Glass Biomedical Implant Material

Additive manufacturing (AM) techniques—including selective laser melting (SLM), electron beam melting (EBM), and binder jetting—have emerged as transformative routes for fabricating patient-specific bulk metallic glass implants with controlled porosity and surface topography 4 5. SLM of Ti-Cu BMG powders (particle size distribution 15–45 μm) employs laser powers of 150–300 W, scan speeds of 200–800 mm/s, and layer thicknesses of 30–50 μm to achieve melt pool cooling rates of 10⁴–10⁶ K/s, sufficient to retain amorphous content >90% 4. Process parameters must be optimized to balance energy density (E = P / (v·h·t), where P is laser power, v is scan speed, h is hatch spacing, and t is layer thickness) to avoid excessive crystallization (E > 100 J/mm³) or lack-of-fusion defects (E < 40 J/mm³) 5.

Post-processing heat treatments in the supercooled liquid region (e.g., 400°C for 10–30 minutes) can homogenize residual stresses and partially crystallize the matrix to form ductile crystalline dendrites (volume fraction 10–30%) that arrest shear band propagation, enhancing fracture toughness from ~20 MPa·m^(1/2) in fully amorphous samples to >50 MPa·m^(1/2) in BMG-matrix composites 15. However, excessive crystallization (>50 vol.%) degrades elastic limit and corrosion resistance, necessitating precise thermal management 13.

Surface Modification And Bioactive Coating Strategies

The inherently hydrophobic and bioinert surfaces of as-cast bulk metallic glass biomedical implant material (contact angles 115–134°) require functionalization to promote cell adhesion, proliferation, and differentiation 14. Tribochemical blasting with bioactive glassy-crystalline particles (60–350 μm grain size) composed of 15–45 wt.% CaO, 40–45 wt.% P₂O₅, 10–40 wt.% ZrO₂, and 0.7–3.5 wt.% fluoride creates surface roughness (Ra = 2–5 μm) and embeds apatite and calcium zirconium phosphate nanocrystals (particle size 50–200 nm) that nucleate hydroxyapatite (HA) formation in physiological fluids 10. Scratch adhesion tests confirm normal critical forces of 10–21 N, ensuring coating durability under physiological loading 14.

Alternative surface treatments include micro-arc oxidation (MAO), which generates porous oxide layers (thickness 5–20 μm, pore diameter 0.5–3 μm) enriched in Ca and P through electrolyte incorporation, and magnetron sputtering of ternary ZrCuX (X = Ca, Mg, Sr, Mo, Si) thin films (thickness ≤2 μm, atomic concentration of X ≤3 at.%) that exhibit hardness of 10–20 GPa and biomineralization weight gains of up to 3.1 mg after 14 days in SBF 14. These coatings reduce ion release rates (e.g., Zr⁴⁺, Cu²⁺) to below cytotoxic thresholds (<10 ppb for Zr, <50 ppb for Cu) while maintaining the substrate's mechanical integrity 14.

Mechanical Properties And Performance Metrics Of Bulk Metallic Glass Biomedical Implant Material

Elastic Modulus, Yield Strength, And Fracture Toughness

Bulk metallic glass biomedical implant material exhibits elastic moduli in the range of 80–120 GPa, intermediate between cortical bone (~20 GPa) and conventional titanium alloys (Ti-6Al-4V: ~110 GPa), reducing stress-shielding effects that lead to bone resorption in load-bearing implants 11 13. Yield strengths typically exceed 1500 MPa 13, with compressive strengths reaching 2000–2500 MPa for Zr-based alloys 19 and 1800–2200 MPa for Ti-Cu systems 5, approximately double those of annealed Ti-6Al-4V (~900 MPa) and stainless steel 316L (~200 MPa).

However, fracture toughness (KIC) of monolithic BMGs remains a critical limitation, with values of 15–30 MPa·m^(1/2) for Zr-based alloys 8 and 10–20 MPa·m^(1/2) for Ti-based systems 5, significantly lower than crystalline Ti-6Al-4V (~80 MPa·m^(1/2)). This brittleness arises from the lack of microstructural barriers to shear band propagation, resulting in catastrophic failure under tensile or bending loads 8. Strategies to enhance toughness include in situ formation of ductile crystalline phases (e.g., β-Ti dendrites, B2 CuZr precipitates) via controlled devitrification 15, ex situ reinforcement with metallic fibers (e.g., stainless steel, tantalum wires with diameters of 50–200 μm) 15, or incorporation of graphite particles (5–20 vol.%, particle size 1–10 μm) that deflect crack tips and promote multiple shear banding 8.

Corrosion Resistance And Ion Release Kinetics

The amorphous structure of bulk metallic glass biomedical implant material confers superior corrosion resistance compared to crystalline alloys, as the absence of grain boundaries, secondary phases, and compositional segregation eliminates galvanic coupling and preferential attack sites 6 13. Potentiodynamic polarization tests in SBF (pH 7.4, 37°C) reveal corrosion current densities (icorr) of 0.01–0.1 μA/cm² for Zr-based BMGs 14, compared to 0.5–2 μA/cm² for Ti-6Al-4V and 5–10 μA/cm² for 316L stainless steel. Corresponding corrosion rates of 0.001–0.01 mm/year ensure implant longevity exceeding 20 years under physiological conditions 13.

Ion release profiles measured via inductively coupled plasma mass spectrometry (ICP-MS) after 30 days of immersion in SBF show cumulative Zr⁴⁺ concentrations of 1–5 ppb for Zr₅₅Cu₂₀Al₁₅Co₁₀ 7, well below the cytotoxicity threshold of 50 ppb established for osteoblast cultures. Mg-based BMG composites exhibit controlled Mg²⁺ release rates of 0.5–2 mg/cm²/day, with hydrogen evolution volumes of 0.1–0.5 mL/cm²/day, manageable through surface passivation and alloy microalloying 1. Ti-Cu alloys release Cu²⁺ at 0.1–1 ppm over 7 days, sufficient for antimicrobial efficacy without exceeding the 10 ppm limit for hepatotoxicity 4.

Wear Resistance And Tribological Performance

The